Farmachem Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.04 M
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -30.45%
- Profit Growth -36.84%
- Ebitda -78.22%
- Net Worth -6.36%
- Total Assets -6.39%
About Farmachem
Farmachem Private Limited (FPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 May 1999 and has a history of 25 years and nine months. Its registered office is in Na, Telangana.
The Corporate was formerly known as Farmachem Sa India Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.04 M, as per Ministry of Corporate Affairs (MCA) records.
Sridhar Balasubramanian, Anuradha Sridhar, and Venkata Chitturi serve as directors at the Company.
Company Details
-
LocationNa, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U52520TG1999PTC042590
-
Company No.
042590
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 May 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Farmachem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridhar Balasubramanian
|
Managing Director | 21-Mar-2000 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anuradha Sridhar
|
Director | 28-Feb-2014 | Current |
|
Venkata Chitturi
|
Whole-Time Director | 01-Apr-2017 | Current |
Financial Performance of Farmachem.
Farmachem Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.45% decrease. The company also saw a substantial fall in profitability, with a 36.84% decrease in profit. The company's net worth dipped by a decrease of 6.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farmachem?
Unlock access to Farmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Farmachem?
Unlock and access historical data on people associated with Farmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
